Therapeutic prostatic thermotherapy

• US 7,093,601 B2
• Filed: 04/02/2003
• Issued: 08/22/2006
• Est. Priority Date: 05/08/1998
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Ams Research Corporation (Endo International PLC)
• Inventors: Turner, Paul F., Schaefermeyer, Theron N., Perlmutter, Aaron P., Sells, Dixie T., Manker, Charles F.
• Primary Examiner(s): PEFFLEY, MICHAEL F
• Application Number:
  US10/405,814
• Publication Number:
  US 20030191513A1
• Time in Patent Office: 1,238 Days
• Field of Search: 606 27- 31, 607 98-105, 607/156, 128/898, 604/22, 604/114
• US Class Current: 128/898
• CPC Class Codes: A61B 18/18 by applying electromagnetic radiation, e.g. microwaves radiation therapy A61N5/00
• CPC Class Codes: A61B 18/1815 using microwaves
• CPC Class Codes: A61B 2017/00084 Temperature
• CPC Class Codes: A61B 2017/00132 Setting operation time of a device A61B2017/00123 takes precedence
• CPC Class Codes: A61B 2017/00274 Prostate operation, e.g. prostatectomy, turp, bhp treatment
• CPC Class Codes: A61B 2018/00547 Prostate

Abstract

The present invention provides a method of treating a prostate in a patient in need thereof and a heating catheter, or an electromagnetic radiation applicator, system suitable for effecting the present inventive method. The present inventive method provides for substantial unexpected improvement in patient outcome by providing, inter alia, a preferred therapeutic temperature for thermotherapy of the prostate and a method of decreasing a patient'"'"'s intolerance due to pain. The present inventive system provides for, inter alia, automatic implementation of the present inventive method.

Claims

1. A method of treating prostate tissue for benign prostatic hyperplasia or prostatitis in a patient having a urethra, comprising the steps of applying energy to the prostate tissue to elevate the temperature of the prostate tissue to a destination temperature and for a time sufficient to achieve a therapeutic effect on said prostate tissue, said energy being applied with a catheter system having:

a catheter for insertion into the urethra;

a heat applicator within the catheter; and

a connector for connecting the applicator to an energy source;

said energy being applied such that the temperature of the prostate tissue is raised from an initial temperature below the destination temperature to a destination temperature in the range of from 490°

C. to about 57°

C. such that the mean rate of increase in temperature is from about 0.5 minute/°

C. to about 15 minute/°

C.

2. The method of claim 1, wherein the destination temperature is in the range of about 50°

C. to about 55°

C.

3. The method of claim 1, wherein the mean rate of increase in temperature is from about 1.0 minute/°

C. to about 10 minutes/°

C.

4. The method of claim 1, wherein the temperature of the prostate tissue is increased from the initial temperature to an intermediate temperature in the range of about 42°

C. to about 46°

C. at a first mean rate of increase; and

the temperature of the prostate tissue is increased from the intermediate temperature to the destination temperature at a second mean rate of increase;

wherein the first mean rate of increase is greater than the second mean rate of increase.

5. The method of claim 1, wherein the mean rate of increase in temperature is selected such that from about 15 minutes to about 2 hours separate the time points when the tissue proximate the applicator rises from the initial temperature to the destination temperature.

6. The method of claim 1, wherein the destination temperature is maintained for a time period less than 2 hours.

7. A method of treating prostate tissue for benign prostatic hyperplasia or prostatitis in a patient having a urethra, comprising the steps of applying energy to the prostate tissue to elevate the temperature of the prostate tissue to a destination temperature and for a time sufficient to achieve a therapeutic effect on said prostate tissue, said energy being applied with a catheter system having:

a catheter for insertion into the urethra;

a heat applicator within the catheter; and

a connector for connecting the applicator to an energy source;

said energy being applied such that the temperature of tissue proximate the applicator is raised from an initial temperature below the destination temperature to a destination temperature in the range of from 49°

C. to about 57°

C., and a thermal dose of about 1500 equivalent 45°

C. minutes to about 30,000 equivalent 45°

C. minutes is applied to the tissue proximate the applicator.

8. The method of claim 7, further comprising the step of gradually increasing the temperature of the tissue proximate the applicator such that the mean rate of increase in temperature is from about 0.5 minute/°

C. to about 15 minutes/°

C.

9. The method of claim 7, further comprising the step of gradually increasing the temperature of the tissue proximate the applicator such that the mean rate of increase in temperature after the temperature range of about 42°

C. to about 46°

C. has been achieved is from about 0.5 minute/°

C. to about 15 minutes/°

C.

10. The method of claim 7, wherein the mean rate of increase in temperature is selected such that from about 15 minutes to about 2 hours separate the time points when the tissue proximate the applicator rises from the initial temperature to the destination temperature.

11. The method of claim 7, wherein a thermal dose of from about 2000 equivalent 45°

C. minutes to about 30,000 equivalent 45°

C. minutes is applied to the tissue proximate the applicator.

12. The method of claim 7, wherein a thermal dose of from about 1500 equivalent 45°

C. minutes to about 20,000 equivalent 45°

C. minutes is applied to the tissue proximate the applicator.

13. A method of treating prostate tissue for benign prostatic hyperplasia or prostatitis in a patient having a urethra, comprising the steps of:

(a) applying power from an energy source to the prostate tissue to elevate the temperature of the prostate tissue to a destination temperature in the range of from about 49°

C. to about 57°

C., such that a mean rate of increase in temperature is from about 0.5 minute/°

C. to about 15 minute/°

C., said power being applied with a catheter system having;

a catheter for insertion into the urethra;

a heat applicator within the catheter; and

a connector for connecting the applicator to the energy source;

(b) defining a plurality of desired treatment temperatures increasing from an initial temperature of the prostate tissue to the destination temperature;

(c) defining a desired treatment duration for each desired treatment temperature;

(d) sensing a temperature representative of the temperature of the prostate tissue;

(e) adjusting the power applied by the energy source until a desired treatment temperature is reached;

(f) maintaining the desired temperature for the desired treatment duration defined for said desired treatment temperature;

(g) repeating steps (d) to (f) until the destination temperature of the prostate tissue is reached;

(h) maintaining the destination temperature for a desired period of time; and

(i) deactivating the energy source after the destination temperature of the prostate tissue has been maintained for the desired period of time.

14. A method of treating prostate tissue for benign prostatic hyperplasia or prostatitis in a patient having a urethra, comprising the steps of:

applying energy from an energy source to the prostate tissue to elevate the temperature of the prostate tissue to a destination temperature in the range of from about 49°

C. to about 57°

C., such that a mean rate of increase in temperature is from about 0.5 minute/°

C. to about 15 minute/°

C., said power being applied with a catheter system having;

a catheter for insertion into the urethra,

a heat applicator within the catheter, and

a connector for connecting the applicator to the energy source;

sensing a temperature representative of the temperature of the prostate tissue;

controlling the energy applied by the energy source based on the sensed temperature until the destination temperature has been reached;

maintaining the destination temperature for a desired period of time; and

deactivating the energy source after the destination temperature of the prostate tissue has been maintained for the desired period of time.

15. The method of claim 14, wherein the step of controlling the energy applied by the energy source further comprising the steps of:

adjusting the energy applied by the energy source to increase the temperature of the prostate tissue; and

maintaining the prostate tissue at preselected treatment temperatures between an initial temperature and the destination temperature for preselected treatment durations.

16. The method of claim 14, wherein the temperature of the prostate tissue is sensed continuously.

17. A method of treating prostate tissue for benign prostatic hyperplasia or prostatitis in a patient having a urethra by means of a catheter system including a catheter for insertion into the urethra, a heat applicator within the catheter and a connector for connecting the heat applicator to an energy source, said method comprising the steps of:

establishing a value of power from said energy source to be applied by said applicator;

determining a value of temperature of the prostate tissue;

adjusting said power from said energy source in dependence on the time the prostate tissue has been at said prostate tissue temperature value; and

computing a value of thermal dosage of said prostate tissue that is a function of said prostate tissue temperature value and the time said prostate tissue has been at said prostate tissue temperature value.

18. The method of claim 17 wherein said thermal dosage value computation step further comprises a function including the product of said prostate tissue temperature and the time said prostate tissue has been at said prostate tissue temperature value.

19. The method of claim 17 further comprising the step of computing a cumulative value of said thermal dosage corresponding to the sum of the values of said thermal dosage at a plurality of values of said prostate tissue temperature.

20. The method of claim 19 further comprising the step of determining a therapeutic effect on said prostate tissue in dependence on a value of said cumulative thermal dosage.

21. The method of claim 20 further comprising the step of correlating said therapeutic effect to a value of prostate tissue necrosis.

22. The method of claim 17 further comprising the step of generating signals indicative of a distribution of said applied power in said prostate tissue proximate to the applicator.

23. The method of claim 19 further comprising the steps of selecting said value of said cumulative thermal dosage to be a thermal dose of about 1500 equivalent 45°

C. minutes to about 30,000 equivalent 45°

C. minutes.

24. The method of claim 17 further comprising the steps of applying to the prostate tissue proximate said applicator a thermal dose of about 1500 equivalent 45°

C. minutes to about 30,000 equivalent 45°

C. minutes.

25. The method of claim 22 further comprising the steps of generating signals corresponding to a distribution of applied power delivered to the tissue proximate to the heat applicator radially away from and along a length of the heat applicator.

26. The method of claim 25 wherein said applied power distribution generating step further comprises the step of generating signals corresponding to a Specific Absorbtion Rate of power in said tissue proximate to the heat applicator.